Fundz

22nd Century

BUFFALO, NY, United States · Agriculture and Farming, Biotechnology, Health Care · 9 employees

22nd Century Group is a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology.

Funding history

  • Series seed — $1.2M — Oct 2024
  • Series seed — $4.2M — Apr 2024
  • Funding Round — $21.0M — Mar 2023
  • Funding Round — $35.0M — Jul 2022
  • Funding Round — $58.0M — May 2022

Recent signals

  • Feb 20, 2026: SEC 8-K (2.02): On February 20, 2026, 22nd Century Group, Inc. issued a preliminary earnings release for the fourth quarter and year ended December 31, 2025. This release provides key financial results and metrics for the period, signifying the company's operational performance and financial condition. The earnings report is included as Exhibit 99.1 in the filing, highlighting developments that may impact shareholder value. Importantly, the information shared in this release is not subject to the typical liabilities under the Exchange Act, implying that it serves as an early indication of financial health rather than a definitive report.
  • Nov 04, 2025: SEC 8-K (1.01): On November 4, 2025, 22nd Century Group, Inc. entered into a Sales Agreement with Needham & Company, LLC, allowing the issuance and sale of common stock with an aggregate offering price of up to $25,000,000. The net proceeds from this At-the-Market (ATM) Offering are intended for general corporate purposes, including the expansion of VLN® reduced nicotine content tobacco products, research and development, and working capital. This agreement signals a strategic move to bolster the company's financial resources for ongoing and future projects.
  • Jul 16, 2025: 22nd Century Group Partners with Tobacco Brands to Promote VLN Reduced Nicotine Cigarettes.
  • Jan 08, 2025: 22nd Century Group (NASDAQ: XXII) and Smoker Friendly Five-Year Licensing and Manufacturing Agreement Announced
  • Oct 04, 2024: Raised $1.2M in Series seed
  • Apr 19, 2024: Raised $4.2M in Series seed
  • Mar 03, 2023: Raised $21.0M
  • Jan 24, 2023: Acquired 22Nd Century Group (Xxii) Acquires Rx Pharmatech Ltd, Greatly Strengthening Uk And Eu Market Position

See plans & pricing → Track 22nd Century’s funding, hiring, and signals — with verified contacts — on Fundz.